Hubei Goto Biopharm Group Co., Ltd. (SHE:300966)
China · Delayed Price · Currency is CNY 31.00
+3.90 (14.39%)
Jun 23, 2026, 3:04 PM CST
Hubei Goto Biopharm Group Market Cap
Hubei Goto Biopharm Group has a market cap or net worth of 3.12 billion as of June 23, 2026. Its market cap has increased by 56.56% in one year.
Market Cap
3.12B
Enterprise Value
4.44B
Revenue
606.18M
Ranking
n/a
PE Ratio
n/a
Stock Price
31.00
Market Cap Chart
Since April 9, 2021, Hubei Goto Biopharm Group's market cap has decreased from 6.57B to 3.12B, a decrease of -52.53%. That is a compound annual growth rate of -13.34%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 22, 2026 | 3.12B | 37.63% |
| Dec 31, 2025 | 2.27B | 21.86% |
| Dec 31, 2024 | 1.86B | -29.78% |
| Dec 29, 2023 | 2.65B | -14.93% |
| Dec 30, 2022 | 3.11B | -34.18% |
| Dec 31, 2021 | 4.73B | -28.02% |
| Apr 9, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Shanghai Obio Technology (Group) Corp. | 3.50B |
| Shanghai Shen Lian Biomedical | 3.46B |
| Baolingbao Biology | 3.39B |
| Pulike Biological Engineering | 3.38B |
| Boji Medical Technology | 3.32B |
| Jiangsu Sihuan Bioengineering | 3.21B |
| Qingdao Vland Biotech INC. | 3.09B |
| Guanhao Biotech | 2.93B |